Clinical Trials Directory

Trials / Completed

CompletedNCT00771992

Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Fraunhofer-Institute of Toxicology and Experimental Medicine · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The effect of surfactant protein D under native and altered conditions will be investigated in immune cells that are derived from bronchoalveolar lavage in patients with allergic asthma following segmental allergen challenge. The goal of this study is to elucidate the pro- versus anti-inflammatory function of SP-D molecules and to identify motifs of SP-D that have treatment potential in allergic asthma.

Detailed description

Following a baseline BAL, allergen (3×) and saline (1×) will be instilled into four different lung segments during a first bronchoscopy. After 24 hours during a second bronchoscopy BAL will be collected in these challenged segments to harvest invaded cells for in-vitro experimentation. In addition, bronchial biopsies and epithelial brushes will be taken to assess the degree of local inflammation in bronchial mucosa and to study the activation of airway epithelium following allergen challenge.

Conditions

Interventions

TypeNameDescription
PROCEDUREBronchoscopyBronchoscopy with segmental allergen challenge

Timeline

Start date
2008-10-01
Primary completion
2009-10-01
Completion
2010-06-01
First posted
2008-10-15
Last updated
2010-08-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00771992. Inclusion in this directory is not an endorsement.